Comparing two clinically relevant mouse models of HCC, platelet-derived growth factor (PDGF)-C overexpressing and PTEN null mice, Lai et al. demonstrated that each model had a specific pattern of integrin gene expression, further indicating HCC heterogeneity [54]. This evidence concerns the gene PTEN and hepatocellular carcinoma.